Good morning.
We hope you all had great summer weekends.
The cannabis industry’s eyes are pinned on the DEA hearings that continue this week. They’re set to wrap up on Wednesday and we’ll have plenty more reporting to come.
Let’s get to it.
-JB, JR
Today’s newsletter is 358 words or about a 3-minute read.
CULTIVATED CALENDAR
This Thurdsay, July 16, Noon Eastern | Investing in the Cannabis Industry | Moby x Cultivated
Cannabis is becoming a mainstream investment. But do you know the difference between a MSO and a Canadian Licensed Producer? Or what Schedule III actually means for valuations?
If you're wondering whether cannabis belongs in your portfolio — and if so, how — this webinar is for you.
Join Moby and Cultivated for a no-nonsense introduction to cannabis industry investing, designed for retail investors who want to understand the opportunity before committing capital — featuring c-suite leaders from some of the industry's most important companies.
Speakers include:
Raj Grover, CEO, High Tide Inc. $HITI ( 0.0% )
Aaron Miles, CIO, Verano $VRNO ( ▼ 0.51% )
Graham Farrar, President, Glass House Brands $GLAS ( ▲ 1.72% )
Michael Gorenstein, President/CEO, Cronos Group $CRON ( ▼ 1.08% )
⏪ In case you missed it
The biggest story in cannabis right now is playing out in a DEA hearing room — and we talked to two people who were actually there. Friday’s This Week in Cannabis Live breaks it all down.
Catch up here »
🗯️ Quotable
“We need nuance in a space where cannabis has been completely demonized or deemed a wonder drug and extremely beneficial,” Johns Hopkins professor Johannes Thrul said, of a recent study he co-authored that found teens who use cannabis had elevated risk of later developing psychiatric disorders. Read more »
🧪 Science & research
Niskanen Center publishes a cannabis market policy playbook 📋
The think tank's new report offers state-by-state recommendations for building and fixing cannabis markets. It calls for a clearer market structure separating producers, distributors, and retailers, enforcement timed to when the legal market can actually compete with illicit sellers, and tax and pricing rules tied to potency rather than weight or price.
📰 What we’re reading